Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%
NCT00604032
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Atralin (tretinoin) Gel, 0.05%
Sponsor
Coria Laboratories, Ltd.